“Full-spectrum commercially-available hemp extract provides dose-dependent anxiolytic benefits in mice”
Wagner, J., Arvila, B., Brooks, M., Webster, H., Reed, K., McGuinness, F., Fees, G., Haryu, T., Predovich, B., & Kaplan, J. S.
So What’s Next?
We will assess various full spectrum hemp-derived CBD oils with varying cannabinoid and terpene compositions because these comparisons will provide important insight into the roles of terpenes and other cannabinoids in the efficacy of cannabis-based treatment.
We will incorporate immunohistochemistry and electrophysiological assessments along with animal behavior to gain insight into the effects of hemp extracts on behavioral symptoms, molecular changes, and brain function.
Our work demonstrates the importance of dose, even from full-spectrum hemp extracts, in CBD’s anxiolytic properties and they shed light on the role of terpenes and minor cannabinoids in these anxiolytic effects.
“Never innovate to compete, innovate to CHANGE the rules of the game.”
- David O. Adeife